Cellular requirements for tumor-specific immunity elicited by heat shock proteins: Tumor rejection antigen gp96 primes CD8<sup>+</sup> T cells in vivo.

UDONO H; LEVEY D L; SRIVASTAVA P K

Art

J-GLOBAL ID：200902102027622754 Reference number：94A0471729

Cellular requirements for tumor-specific immunity elicited by heat shock proteins: Tumor rejection antigen gp96 primes CD8⁺ T cells in vivo.

熱ショック蛋白質により誘導される腫よう特異的免疫に必要とされる細胞腫よう拒絶抗原gp96はCD8⁺T細胞をin vivoで感作する

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=94A0471729&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=94A0471729&from=J-GLOBAL&jstjournalNo=D0387A") }}

Author (3)： , ,
Material：
Volume： 91 Issue： 8 Page： 3077-3081 Publication year： Apr. 12, 1994
JST Material Number： D0387A ISSN： 0027-8424 Document type： Article
Article type：原著論文 Country of issue： United States (USA) Language： ENGLISH (EN)

,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=94A0471729&from=J-GLOBAL&jstjournalNo=D0387A") }}

Tumor immunity

, , , , , , , ,

Return to Previous Page

Cellular requirements for tumor-specific immunity elicited by heat shock proteins: Tumor rejection antigen gp96 primes CD8+ T cells in vivo.

Cellular requirements for tumor-specific immunity elicited by heat shock proteins: Tumor rejection antigen gp96 primes CD8⁺ T cells in vivo.